Genicular Nerve Block in Rheuamtoid Arthritis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
N=64 RA patients either early or established disease diagnosed after ACR/EULAR criteria 2010 with unilateral persistent knee arthritis. They were randomly assigned into two groups; group 1 received genicular nerve block, group 2 intra-articular triamcinolone. Both groups were examined by SOLAR scoring system, Visual analogue scale (VAS) and Lysholm score at 0, 2 and 12 weeks. A semi-quantitative score was used to assess tenderness and swelling at the same intervals.
Epistemonikos ID: 0dd3ee8a839cfe3297420caa24154a54653b0f7a
First added on: May 07, 2024